Bone loss or lost bone: Rationale and recommendations for the diagnosis and treatment of early postmenopausal bone loss

Current Osteoporosis Reports

Volumn 7, Issue 4, 2009, Pages 118-126

  Zaidi, Mone ^a   Turner, Charles H ^b   Canalis, Ernesto ^b   Pacifici, Roberto ^b   Sun, Li ^b   Iqbal, Jameel ^b   Guo, X Edward ^b   Silverman, Stuart ^b   Epstein, Solomon ^b   Rosen, Clifford J ^b  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

ALENDRONIC ACID; AMINO TERMINAL TELOPEPTIDE; ESTRADIOL; ESTROGEN; FOLLITROPIN; LUTEINIZING HORMONE; OSTEOCALCIN; RALOXIFENE; RISEDRONIC ACID;

ALBERS SCHOENBERG DISEASE; BONE DENSITY; BONE DISEASE; BONE REMODELING; BONE STRENGTH; BONE TURNOVER; CLIMACTERIUM; CLINICAL TRIAL; COMPUTER ASSISTED TOMOGRAPHY; ESTRADIOL BLOOD LEVEL; FRAGILITY FRACTURE; HIP FRACTURE; HUMAN; LUMBAR SPINE; MENSTRUAL CYCLE; NUCLEAR MAGNETIC RESONANCE IMAGING; OSTEOLYSIS; POSTMENOPAUSE OSTEOPOROSIS; REVIEW;

BONE DENSITY; BONE DENSITY CONSERVATION AGENTS; BONE REMODELING; FEMALE; FRACTURES, SPONTANEOUS; HUMANS; OSTEOPOROSIS, POSTMENOPAUSAL; PERIMENOPAUSE; RISK ASSESSMENT;

EID: 72849125316     PISSN: 15441873     EISSN: 15442241     Source Type: Journal    
DOI: 10.1007/s11914-009-0021-4     Document Type: Review

References (46)

1. Stepnick LS: The frequency of bone disease. In Bone Health and Osteoporosis: A Report of the Surgeon General. Edited by McGowan JA, Raisz LG, Noonan AS, Elderkin AL. Washington, DC: Office of the US Surgeon General; 2004:68-87.
2. M. Zaidi 2007 Skeletal remodeling in health and disease Nat Med 13 791 801 10.1038/nm1593 1:CAS:528:DC%2BD2sXnsFWmtro%3D 17618270 (Pubitemid 47038187)
3. P.D. Miller 2006 Guidelines for the diagnosis of osteoporosis: Tscores vs fractures Rev Endocrinol Metabol Disord 7 75 89 10.1007/s11154-006-9006-0 (Pubitemid 46044350)
4. C.H. Turner 2006 Bone strength: current concepts Ann N Y Acad Sci 1068 429 446 10.1196/annals.1346.039 16831941 (Pubitemid 43824172)
5. N.B. Watts P. Geusens I.P. Barton D. Felsenberg 2005 Relationship between changes in BMD and nonvertebral fracture incidence associated with risedronate: reduction in risk of nonvertebral fracture is not related to change in BMD J Bone Miner Res 20 2097 2104 10.1359/JBMR.050814 16294263 (Pubitemid 41698773)
6. S.R. Cummings D.B. Karpf F. Harris, et al. 2002 Improvement in spine bone density and reduction in risk of vertebral fractures during treatment with antiresorptive drugs Am J Med 112 281 289 10.1016/S0002-9343(01)01124-X 1:CAS:528:DC%2BD38XhvVWkurk%3D 11893367 (Pubitemid 34219441)
7. FRAX: WHO Fracture Risk Assessment Tool. Available at http://www.sheffield.ac.uk/FRAX. Accessed October 1, 2009.
8. M.R. Sowers M. Jannausch D. McConnell, et al. 2006 Hormone predictors of bone mineral density changes during the menopausal transition J Clin Endocrinol Metab 91 1261 1267 10.1210/jc.2005-1836 1:CAS:528:DC%2BD28XjvFOks7k%3D 16403818
9. M.P. Akhter J.M. Lappe K.M. Davies R.R. Recker 2007 Transmenopausal changes in trabecular bone structure Bone 41 111 116 10.1016/j.bone.2007.03.019 1:STN:280:DC%2BD2szls1ensQ%3D%3D 17499038 (Pubitemid 46891901)
10. N.D. Nguyen H.G. Ahlborg J.R. Center, et al. 2007 Residual lifetime risk of fracture in men and women J Bone Miner Res 22 781 788 10.1359/jbmr.070315 17352657 (Pubitemid 351339737)
11. S. Epstein A.M. Inzerillo J. Caminis M. Zaidi 2003 Disorders associated with acute rapid and severe bone loss J Bone Miner Res 18 2083 2084 10.1359/jbmr.2003.18.12.2083 14672343 (Pubitemid 37463302)
12. E. Canalis G. Mazziotti A. Giustina J. Bilezikian 2007 Glucocorticoid-induced osteoporosis: pathophysiology and therapy Osteoporosis Int 18 1319 1328 10.1007/s00198-007-0394-0 1:CAS:528:DC%2BD2sXhtVagurrN (Pubitemid 47389469)
13. M.B. Schaffler K. Choi C. Milgrom 1995 Aging and matrix microdamage accumulation in human compact bone Bone 17 521 525 10.1016/8756-3282(95)00370-3 1:STN:280:DyaK28vjt1aguw%3D%3D 8835305 (Pubitemid 26017572)
14. S.C. Schuit M. van der Klift A.E. Weel, et al. 2004 Fracture incidence and association with bone mineral density in elderly men and women: the Rotterdam Study Bone 34 195 202 10.1016/j.bone.2003.10.001 1:STN:280: DC%2BD2c%2FltVCjsg%3D%3D 14751578 (Pubitemid 38142449)
15. S. Sarkar B.H. Mitlak M. Wong, et al. 2002 Relationships between bone mineral density and incident vertebral fracture risk with raloxifene therapy J Bone Miner Res 17 11 14 10.1359/jbmr.2002.17.1.1
16. D.W. Dempster 2000 The contribution of trabecular architecture to cancellous bone quality J Bone Miner Res 15 20 23 10.1359/jbmr.2000.15.1.20 1:STN:280:DC%2BD3c7htFGkuw%3D%3D 10646110
17. C. Li 2006 Mice lacking cathepsin K maintain bone remodeling but develop bone fragility despite high bone mass J Bone Miner Res 21 865 875 10.1359/jbmr.060313 1:CAS:528:DC%2BD28XlvVamtbY%3D 16753017 (Pubitemid 43787993)
18. M.H. Lafage R. Balena M.A. Battle, et al. 1995 Comparison of alendronate and sodium fluoride effects on cancellous and cortical bone in mini-pigs. A one-year study J Clin Invest 95 2127 2133 10.1172/JCI117901 1:CAS:528: DyaK2MXltlWrt7Y%3D 7738180
19. S.L. Silverman 2007 Selecting patients for osteoporosis therapy Ann N Y Acad Sci 1117 264 272 10.1196/annals.1402.042 18056046 (Pubitemid 350191279)
20. Sandhu SK, Nguyen ND, Center JR, et al.: Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram. Osteoporosis Int 2009 Jul 25 (Epub ahead of print).
21. M.R. Sowers G.A. Greendale I. Bondarenko, et al. 2003 Endogenous hormones and bone turnover markers in pre- and perimenopausal women: SWAN Osteoporosis Int 14 191 197 10.1007/s00198-002-1307-x 1:CAS:528:DC%2BD3sXlslOls7k%3D (Pubitemid 36267900)
22. V. Seifert-Klauss J.E. Mueller P. Luppa, et al. 2002 Bone metabolism during the perimenopausal transition: a prospective study Maturitas 41 23 33 10.1016/S0378-5122(01)00248-1 1:CAS:528:DC%2BD38XmsFGgtg%3D%3D 11809340 (Pubitemid 34102386)
23. R. Recker J. Lappe K.M. Davies R. Heaney 2004 Bone remodeling increases substantially in the years after menopause and remains increased in older osteoporosis patients J Bone Miner Res 19 1628 1633 10.1359/JBMR.040710 15355557 (Pubitemid 41094325)
24. X.S. Liu P. Sajda P.K. Saha, et al. 2006 Quantification of the roles of trabecular microarchitecture and trabecular type in determining the elastic modulus of human trabecular bone J Bone Miner Res 21 1608 1617 10.1359/jbmr.060716 16995816 (Pubitemid 44484606)
25. S.L. Bonnick I. Shulman 2006 Monitoring osteoporosis therapy: bone mineral density, bone turnover markers or both? Am J Med 119S S25 S31 10.1016/j.amjmed.2005.12.020
26. P.R. Ebeling L.M. Atley J.R. Guthrie, et al. 1996 Bone turnover markers and bone density across the menopausal transition J Clin Endocrinol Metab 81 3366 3371 10.1210/jc.81.9.3366 1:CAS:528:DyaK28Xls1OrtLk%3D 8784098 (Pubitemid 26296217)
27. R.D. Chapurlat P. Garnero E. Sornay-Rendu, et al. 2000 Longitudinal study of bone loss in pre and perimenopausal women: evidence for bone loss in perimenopausal women Osteoporosis Int 11 493 498 10.1007/s001980070091 1:STN:280:DC%2BD3cvotFSiuw%3D%3D (Pubitemid 30681646)
28. C.J. Rosen C.H. Chestnut III N.J. Mallinak 1997 The predictive value of biochemical markers of bone turnover for bone mineral density in early postmenopausal women treated with hormone replacement or calcium supplementation J Clin Endocrinol Metab 82 1904 1910 10.1210/jc.82.6.1904 1:CAS:528: DyaK2sXjs1ent7Y%3D 9177404
29. E. Seeman G. Bianchi S. Khosla, et al. 2006 Bone fragility in men: where are we Osteoporosis Int 17 1577 1583 10.1007/s00198-006-0160-8 1:STN:280:DC%2BD28rotlagsw%3D%3D (Pubitemid 44477616)
30. S. Khosla B.L. Riggs E.J. Atkinson, et al. 2006 Effects of sex and age on bone microstructure at the ultradistal radius: a population-based non-invasive in vivo assessment J Bone Miner Res 21 124 131 10.1359/JBMR.050916 16355281 (Pubitemid 43023234)
31. T.M. Keaveny D.W. Donley P.F. Hoffmann, et al. 2007 Effects of teriparatide and alendronate on vertebral strength as assessed by finite element modeling of QCT scans in women with osteoporosis J Bone Miner Res 22 149 157 10.1359/jbmr.061011 1:CAS:528:DC%2BD2sXhtVWnurk%3D 17042738 (Pubitemid 46032608)
32. M. Kleerekoper 2006 Osteoporosis prevention and therapy: preserving and building strength through bone quality Osteoporosis Int 17 1707 1715 10.1007/s00198-006-0187-x 1:STN:280:DC%2BD28nitVSltQ%3D%3D (Pubitemid 44607390)
33. M.R. McClung R.D. Wasnich D.J. Hosking, et al. 2004 Prevention of postmenopausal bone loss: six year results from the Early Postmenopausal Intervention Cohort Study J Clin Endocrinol Metab 89 4879 4885 10.1210/jc.2003-031672 1:CAS:528:DC%2BD2cXovVenu7w%3D 15472179 (Pubitemid 39391422)
34. P. Ravn S.R. Weiss J.A. Rodriguez-Portales, et al. 2000 Alendronate in early post-menopausal women: effects on bone mass during long-term treatment and after withdrawal. Alendronate Osteoporosis Prevention Study Group J Clin Endocrinol Metab 85 1492 1497 10.1210/jc.85.4.1492 1:CAS:528: DC%2BD3cXisFOquro%3D 10770187 (Pubitemid 32289491)
35. L. Mortensen P. Charles P.J. Bekker, et al. 1998 Risedronate increases bone mass in an early post-menopausal population: two years of treatment plus one year of follow-up J Clin Endocrinol Metab 83 396 402 10.1210/jc.83.2.396 1:CAS:528:DyaK1cXhtVSmsro%3D 9467547 (Pubitemid 28496512)
36. M.J. Hooper P.R. Ebeling A.P. Roberts, et al. 2005 Risedronate prevents bone loss in early post-menopausal women: a prospective, randomized, placebo-controlled trial Climacteric 8 251 262 10.1080/13697130500118126 1:CAS:528:DC%2BD2MXhtVOrtbzO 16390757 (Pubitemid 41224437)
37. D.M. Black A.V. Schwartz K.E. Ensrud, et al. 2006 Effects of continuing or stopping alendronate after 5 years of treatment the Fracture Intervention Trial Long-arm Extension (FLEX): a randomized trial JAMA 296 2927 2938 10.1001/jama.296.24.2927 1:CAS:528:DC%2BD2sXnvVGh 17190893 (Pubitemid 46021497)
38. M.R. McClung R.D. Wasnich R. Recker, et al. 2004 Oral daily ibandronate prevents bone loss in early postmenopausal women without osteoporosis J Bone Miner Res 19 11 18 10.1359/JBMR.0301202 1:CAS:528:DC%2BD2cXnt1KhtQ%3D%3D 14753731 (Pubitemid 43328575)
39. K.K. Steinberg L.W. Freni-Titulaer E.G. DePuey, et al. 1989 Sex steroids and bone density in premenopausal and perimenopausal women J Clin Endocrinol Metab 69 533 539 10.1210/jcem-69-3-533 1:CAS:528:DyaL1MXlsVKqtb0%3D 2527242
40. G. Perrone P. Galoppi O. Capri, et al. 1995 Lumbar and femoral bone density in perimenopausal women with irregular cycles Int J Fertil Menopausal Stud 40 120 125 1:STN:280:DyaK2Mzpt1GqtA%3D%3D 7663538
41. M. Ito T. Nakamura K. Tsurusaki, et al. 1999 Effects of menopause on age-dependent bone loss in the axial and appendicular skeletons in healthy Japanese women Osteoporosis Int 10 377 383 10.1007/s001980050243 1:STN:280:DC%2BD3c7ht1Kquw%3D%3D
42. R. Recker J. Lappe K. Davies R. Heaney 2001 Characterization of perimenopausal bone loss: a prospective study J Bone Miner Res 15 1965 1973 10.1359/jbmr.2000.15.10.1965
43. M.R. Sowers J.S. Finkelstein B. Ettinger, et al. 2003 The association of endogenous hormone concentrations and bone mineral density measures in pre- and perimenopausal women of four ethnic groups: SWAN Osteoporosis Int 14 44 52 10.1007/s00198-002-1307-x 1:CAS:528:DC%2BD3sXpvFOqsA%3D%3D (Pubitemid 36267900)
44. V. Seifert-Klauss T. Link C. Heumann, et al. 2006 Influence of pattern of menopausal transition on amount of trabecular bone loss. Results from a 6-year prospective longitudinal study Maturitas 55 317 324 10.1016/j.maturitas.2006.04. 024 1:STN:280:DC%2BD28nmtlOjtg%3D%3D 16781095 (Pubitemid 44693069)
45. J.F. Randolph Jr M. Sowers I.V. Bondarenko, et al. 2004 Change in estradiol and follicle-stimulating hormone across the early menopausal transition: effects of ethnicity and age J Clin Endocrinol Metab 89 1555 1561 10.1210/jc.2003-031183 1:CAS:528:DC%2BD2cXjt1els7g%3D 15070912 (Pubitemid 38507902)
46. X.E. Guo C.H. Kim 2002 Mechanical consequence of trabecular bone loss and its treatment: a three-dimensional model simulation Bone 30 404 411 10.1016/S8756-3282(01)00673-1 1:STN:280:DC%2BD387kvVKgsw%3D%3D 11856649 (Pubitemid 34150164)